A transcription factor SmERF105 that synergistically regulates tanshinone biosynthesis and transport and its applications

By co-regulating the biosynthesis and transport of tanshinone by the transcription factor SmERF105, the problem of unstable quality of tanshinone was solved, the content of tanshinone and the quality of the medicinal material were improved, and the sustainable utilization of Chinese medicinal resources was promoted.

CN123063407APending Publication Date: 2026-11-10SHANGHAI UNIV OF T C M
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510583049.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-05-07
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

In existing technologies, the regulation of the biosynthesis and transport process of tanshinone in medicinal plants mainly focuses on the regulation of pathway genes, neglecting the transport process. This leads to unstable quality of tanshinone and degradation of medicinal quality under traditional cultivation methods.

Method used

We discovered and utilized the transcription factor SmERF105 to recognize and bind to the GCC-box sequences in the promoter regions of the tanshinone biosynthesis pathway genes KSL1, CYP76AH3, and the transport gene ABCG1, thereby synergistically regulating the biosynthesis and transport of tanshinone and achieving efficient regulation through genetic engineering.

Benefits of technology

It improved the biosynthesis and transport of tanshinone, increased the content of tanshinone in medicinal materials, improved the quality of medicinal materials, and promoted the sustainable utilization of Chinese medicinal resources.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123063407A_ABST
    Figure CN123063407A_ABST
Patent Text Reader

Abstract

This invention belongs to the pharmaceutical field, specifically relating to a transcription factor SmERF105 that synergistically regulates the biosynthesis and transport of tanshinone and its applications. The transcription factor SmERF105 of this invention can recognize and bind to the GCC-box sequences in the promoter regions of the tanshinone biosynthesis pathway genes KSL1, CYP76AH3, and the transport gene ABCG1, activating transcription and synergistically regulating the biosynthesis and transport of tanshinone. This provides a new direction for improving tanshinone production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of medicine, specifically relating to a transcription factor SmERF105 that synergistically regulates the biosynthesis and transport of tanshinone and its applications. Background Technology

[0002] Active ingredients in medicinal plants are the core material basis of medicinal materials, and their levels directly affect the efficacy of the medicine. The accumulation of active ingredients in plants is affected by both biosynthesis and transport; therefore, the accumulation of active ingredients in medicinal plants is closely related to pathway genes and transport genes. Secondly, gene expression is regulated by transcription factors; therefore, identifying key transcriptional regulators is crucial for understanding the molecular mechanisms of active ingredient accumulation in medicinal plants, and can be used for quality control of traditional Chinese medicine and molecular-assisted breeding. However, current research on transcription factors in medicinal plants focuses on the regulation of pathway genes, neglecting the transport process.

[0003] Salvia miltiorrhiza is a model plant for medicinal plant research. Tanshinone compounds are lipid-soluble phenanthrenequinone compounds with antibacterial effects extracted from the medicinal herb Salvia miltiorrhiza, exhibiting well-defined pharmacological activities. As a perennial herb with a long growth cycle, traditional cultivation methods result in unstable quality and deterioration of the medicinal material. How to obtain active ingredients and improve the quality of the medicinal material in a green and efficient manner is a key focus of research in the field of traditional Chinese medicine resources. Utilizing genetic engineering to regulate the quality of key regulatory factors in traditional Chinese medicine and molecular-assisted breeding can improve the quality of Salvia miltiorrhiza, obtain superior strains, and promote the sustainable utilization of traditional Chinese medicine resources. Therefore, identifying highly efficient regulatory factors affecting the accumulation of active ingredients is crucial. Summary of the Invention

[0004] This invention has found that the transcription factor SmERF105 can recognize and bind to the GCC-box sequence of the promoter region of the tanshinone biosynthesis pathway genes KSL1, CYP76AH3 and the transport gene ABCG1, and activate transcription, thereby synergistically regulating the biosynthesis and transport of tanshinone.

[0005] This invention provides a transcription factor SmERF105 that synergistically regulates the biosynthesis and transport of tanshinone.

[0006] Another aspect of the present invention provides the application of the transcription factor SmERF105, which synergistically regulates the biosynthesis and transport of tanshinone.

[0007] The technical solution of this invention is as follows:

[0008] This invention provides a transcription factor SmERF105 that synergistically regulates the biosynthesis and transport of tanshinone, the nucleotide sequence of which contains at least one of the following:

[0009] a. The nucleotide sequence shown in SEQ ID NO.1; or

[0010] b. A nucleotide sequence complementary to the nucleotide sequence shown in SEQ ID NO. 1; or

[0011] c. A nucleotide sequence that overlaps with the nucleotide sequence shown in SEQ ID NO.1 and has the same coding function; or

[0012] d. A nucleotide sequence that hybridizes to the nucleotide sequence shown in SEQ ID NO:1 and has the same coding function; or

[0013] e. The nucleotide sequences amplified by at least one of the following primer pairs:

[0014] 1) SEQ ID NO.3 and SEQ ID NO.4;

[0015] 2) SEQ ID NO.6 and SEQ ID NO.7;

[0016] 3) SEQ ID NO.20 and SEQ ID NO.21;

[0017] 4) SEQ ID NO.39 and SEQ ID NO.40;

[0018] 5) SEQ ID NO. 55 and SEQ ID NO. 56; or

[0019] A gene mutation is performed on the nucleotide sequences of a, b, c, d, or e to obtain nucleotide sequences with the same coding function; or

[0020] A nucleotide sequence having at least 70% homology with the nucleotide sequences in a, b, c, d, or e and having the same coding function, preferably at least 80% homology with the same coding function, more preferably at least 90% homology with the same coding function, more preferably at least 95% homology with the same coding function, and even more preferably at least 98% homology with the same coding function.

[0021] The gene mutations described in this invention refer to changes in the composition or sequence of base pairs, including but not limited to base substitution mutations, frameshift mutations, deletion mutations, and insertion mutations. Base substitution mutations further include transition mutations and transversion mutations. A transition mutation occurs when one purine is replaced by another purine or one pyrimidine is replaced by another pyrimidine; a transversion mutation occurs when a purine replaces a pyrimidine or a pyrimidine replaces a purine. Based on the four bases in a DNA molecule, there are potentially four types of transition mutations and eight types of transversion mutations. A frameshift mutation refers to the insertion or loss of one or more base pairs at a specific site, causing a misalignment in the sequence of the coding sequence following the insertion or loss site. A deletion mutation refers to the deletion of a DNA fragment. An insertion mutation refers to the insertion of a foreign DNA fragment.

[0022] The transcription factor SmERF105 that synergistically regulates the biosynthesis and transport of tanshinone provided by the present invention can be used to prepare products for cloning and / or encoding expression of transcription factor SmERF105, or transcription factor SmERF105 polypeptides or proteins, including but not limited to nucleic acid constructs, vectors, cells, tissues, organs, plants, etc.

[0023] This invention also provides a nucleic acid construct containing the transcription factor SmERF105, which is described above as a co-regulatory transcription factor for the biosynthesis and transport of tanshinone, and a regulatory sequence, including but not limited to promoters, enhancers, and terminators. This nucleic acid construct possesses the components required for the encoding and expression of transcription factor SmERF105, thereby achieving the encoding and expression of transcription factor SmERF105.

[0024] This invention also provides a vector containing the transcription factor SmERF105, which is described above as a synergistic regulator of tanshinone biosynthesis and transport, and / or one of the above-described nucleic acid constructs. The vectors of this invention have cloning and / or expression functions, including but not limited to plasmid vectors, phage vectors, viral vectors, artificial chromosome vectors (yeast or bacteria, etc.), granular vectors, such as the pEASY series, pEAQ series, pB42AD, pET series, pGEX series, pGreen series, etc., and further examples such as pEASY-Blunt Zero Cloning Vector, pEAQ-GFP, pB42AD, pET-28a, pGEX-4T-1, pGreenII0800, pGreenII 62-SK, etc.

[0025] This invention also provides a cell containing the aforementioned transcription factor SmERF105, which co-regulates the biosynthesis and transport of tanshinone, and / or the aforementioned nucleic acid construct and / or the aforementioned vector. In this cell, the aforementioned transcription factor SmERF105, which co-regulates the biosynthesis and transport of tanshinone, and / or the aforementioned nucleic acid construct and / or the aforementioned vector can be cloned and replicated, and / or encode and express the transcription factor SmERF105. The cells include, but are not limited to, *Escherichia coli* cells, *Agrobacterium* cells, yeast cells, and plant cells. Plant cells are cells with tanshinone biosynthesis and transport functions, including but not limited to plants of the Lamiaceae, Polygonaceae, and Asteraceae families, such as *Salvia miltiorrhiza*, *Polygonum multiflorum*, and chrysanthemum. Methods for introducing the target gene into plant cells include, but are not limited to, *Agrobacterium*-mediated transformation, gene gun method, electroporation method, pollen tube pathway method, and microinjection method. The *E. coli* cells are derived from competent *E. coli* cells, including but not limited to Trans1T-1, DH5α, TOP10, Turner(DE3), JM109, and XL1-Blue. The transcription factor SmERF105, which co-regulates the biosynthesis and transport of tanshinone as described above, and / or one of the aforementioned nucleic acid constructs, and / or one of the aforementioned vectors, are introduced into *E. coli* cells through competent *E. coli* cells. The *Agrobacterium* cells are derived from competent *Agrobacterium* cells, including but not limited to EHA105, GV3101, C58C1, and LBA4404. The transcription factor SmERF105, which co-regulates the biosynthesis and transport of tanshinone as described above, and / or one of the aforementioned nucleic acid constructs, and / or one of the aforementioned vectors, are introduced into *Agrobacterium* cells through competent *Agrobacterium* cells. Yeast cells are derived from competent yeast cells, including but not limited to EGY48, GAL4, LexA, DUALmembrane, YIHGold-pAbAi, Y187-pHis2, AH109, ​​Y190, etc. The transcription factor SmERF105, which is a co-regulatory transcription factor for the biosynthesis and transport of tanshinone, and / or a nucleic acid construct and / or a vector described above, are introduced into the yeast cells through competent yeast cells.

[0026] The present invention also provides a transcription factor SmERF105 polypeptide or protein, the amino acid sequence of which comprises at least one of the following:

[0027] a. The amino acid sequence shown in SEQ ID NO.2; or

[0028] b. The amino acid sequence encoded by the transcription factor SmERF105, which synergistically regulates the biosynthesis and transport of tanshinone, as described above in this invention; or

[0029] c. The amino acid sequence encoded by one of the nucleic acid constructs of the present invention; or

[0030] d. The amino acid sequence encoded by the vector described above in this invention; or

[0031] e. The above-described cell-encoded amino acid sequence of the present invention; or

[0032] f. A sequence having at least 70% homology with the amino acid sequence in a, or b, or c, or d, or e, preferably at least 80% homology, more preferably at least 90% homology, more preferably at least 95% homology, and even more preferably at least 98% homology.

[0033] This invention also provides a plant, plant tissue, or plant organ containing the aforementioned transcription factor SmERF105, which synergistically regulates the biosynthesis and transport of tanshinone, and / or the aforementioned nucleic acid construct, and / or the aforementioned vector, and / or the aforementioned cell, and / or the aforementioned transcription factor SmERF105 polypeptide or protein. Plant tissues are structures intermediate between cells and organs, composed of morphologically similar cells and intercellular matrix. Plant organs include, but are not limited to, roots, stems, leaves, flowers, fruits, and seeds.

[0034] The present invention relates to a transcription factor SmERF105 that synergistically regulates the biosynthesis and transport of tanshinone, and / or a nucleic acid construct, and / or a vector, and / or a cell, and / or a polypeptide or protein of the transcription factor SmERF105, and / or a plant, plant tissue, or plant organ that can be used to synergistically regulate the biosynthesis and transport of tanshinone, or to prepare products that synergistically regulate the biosynthesis and transport of tanshinone for the regulation of tanshinone biosynthesis and transport. These products include, but are not limited to, reagents, kits, additives, nutrient solutions, culture media, modifiers, biomaterials, biochips, devices, or equipment.

[0035] The present invention also provides a product containing the transcription factor SmERF105, which is described above as a synergistic regulator of tanshinone biosynthesis and transport, and / or the above-described nucleic acid construct, and / or the above-described vector, and / or the above-described cell, and / or the above-described transcription factor SmERF105 polypeptide or protein, and / or a plant or plant tissue or plant organ, thereby achieving synergistic regulation of tanshinone biosynthesis and transport.

[0036] The present invention also provides a method for regulating the biosynthesis and transport of tanshinone, comprising the steps of: culturing the nucleotide sequence of the transcription factor SmERF105 that synergistically regulates the biosynthesis and transport of tanshinone as described above, and / or a nucleic acid construct as described above, and / or a vector as described above, and / or a cell as described above, and / or a polypeptide or protein of the transcription factor SmERF105 as described above, and / or a plant or plant tissue or plant organ.

[0037] This invention also provides a primer pair for amplification or detection of the transcription factor SmERF105, which regulates the biosynthesis and transport of tanshinone, containing at least one of the following:

[0038] 1) SEQ ID NO.3 and SEQ ID NO.4;

[0039] 2) SEQ ID NO.6 and SEQ ID NO.7;

[0040] 3) SEQ ID NO.20 and SEQ ID NO.21;

[0041] 4) SEQ ID NO.39 and SEQ ID NO.40;

[0042] 5) SEQ ID NO.55 and SEQ ID NO.56.

[0043] The primer pair provided above for amplification or detection of transcription factor SmERF105, which regulates the biosynthesis and transport of tanshinone, can be used to amplify or detect transcription factor SmERF105 and to prepare products for amplification or detection of transcription factor SmERF105. The products include, but are not limited to, reagents, kits, biomaterials, biochips, devices or equipment.

[0044] This invention provides a product for amplifying or detecting transcription factor SmERF105, containing the primer pair for amplifying or detecting SmERF105, a transcription factor that regulates the biosynthesis and transport of tanshinone, as provided above.

[0045] This invention discovers that the transcription factor SmERF105 has a positive regulatory effect on the biosynthesis and transport of tanshinone, thereby regulating the content of tanshinone in tanshinone medicinal materials, improving the quality of medicinal materials, and promoting the sustainable utilization of Chinese medicinal resources. Attached Figure Description

[0046] Figure 1 This is a schematic diagram of the GCC-box distribution in the promoters of two tanshinone component pathway genes and transporter protein encoding genes.

[0047] Figure 2 The results are for one-hybridization of SmERF105 yeast.

[0048] Figure 3 The peaks represent the chromatographic absorption peaks of the SmERF105 recombinant protein.

[0049] Figure 4 The results are from the SmERF105 EMSA experiment.

[0050] Figure 5 The results of dual-luciferase experiments using SmERF105 and CYP76AH3, KSL1, and ABCG1 promoters in tobacco leaves.

[0051] Figure 6 A schematic diagram of the carrier construction.

[0052] Figure 7 It is a positive gene knockout line.

[0053] Figure 8 The relative expression levels of pathway genes in the gene knockout SmERF105 strain (n=3, * indicates P<0.05, ** indicates P<0.01, *** indicates P<0.001).

[0054] Figure 9 To determine the content of tanshinone (Tanshinone IIA, Tanshinone I, Cryptotanshione, Dihydrotanshinone I) in the gene knockout SmERF105 Danshen strain (n=3, * indicates P<0.05, ** indicates P<0.01, *** indicates P<0.001). Detailed Implementation

[0055] The technical solution of the present invention will be described below with specific embodiments, but these are not intended to limit the scope of protection of the present invention.

[0056] In the following examples, unless otherwise specified, the reagents or instruments are conventional reagents or instruments, which can be purchased from any conventional reagent or instrument manufacturer or distributor.

[0057] I. Cloning of transcription factor SmERF105

[0058] 1. Extraction of total RNA and preparation of cDNA from Salvia miltiorrhiza

[0059] a. After quickly cleaning the roots of *Salvia miltiorrhiza*, cut them into small sections with an RNase-free blade, place them in a 1.5 mL EP tube without RNase, add grinding beads, and immediately freeze in liquid nitrogen. Pre-cool the grinder, quickly transfer the EP tube into the grinder, and grind three times at 55 Hz for 10 seconds each time;

[0060] b. Use the TransZol Up Plus RNAKit (ER501-01-V2, TransGen (Beijing)) to extract total RNA. Take out the EP tube, add 1 mL of TransZol Up, pipette and mix well, and let stand at room temperature for 5 min.

[0061] c. Add 200 μL of chloroform, shake thoroughly, and let stand at room temperature for 3 minutes;

[0062] d. 10000g, centrifuged at low temperature for 15min;

[0063] e. Transfer the supernatant to a clean EP tube, add an equal volume of anhydrous ethanol, and gently invert to mix.

[0064] f. Transfer to a centrifuge column and centrifuge at 10000g for 30s;

[0065] g. Add 500 μL of CB9, centrifuge at 12000g for 30 seconds at room temperature, and discard the eluent. Repeat this step once;

[0066] h. Add 500 μL of WB9, as above;

[0067] i. Centrifuge at 12000g for 2 minutes to remove ethanol;

[0068] j. Transfer the centrifuge column to an RNA-free EP tube, add 50 μL of RNase-free water, and let stand for 1 min;

[0069] k. Centrifuge at 12000g for 1 min at room temperature, run gel electrophoresis to identify RNA quality and determine RNA concentration;

[0070] 1. Prepare the reverse transcription system according to the reverse transcription kit instructions to obtain Danshen cDNA.

[0071] 2. Gene cloning

[0072] Using SmERF105-F and SmERF105-R as primers, and obtaining tanshinone cDNA as a template, PCR amplification was performed using the KOD-FX (KFX-101, Toyobo (Japan)) enzyme reaction system. The primer sequences are shown in Table 1.1, the reaction system is shown in Table 1.2, and the reaction procedure is shown in Table 1.3.

[0073] Table 1.1 Primer Information

[0074]

[0075] Table 1.2 PCR System

[0076]

[0077] Table 1.3 Reaction Procedure

[0078]

[0079] 3. Gel recovery and purification of PCR products

[0080] a. Run PCR products for agarose gel electrophoresis at 150V for 25 minutes;

[0081] b. Cut the target band under the gel imaging system and place it in a clean centrifuge tube. Add 300 μL of Buffer DE-A solution and incubate in a water bath at 65°C for about 7 minutes until the gel is completely dissolved. Add half the volume of Buffer DE-A and Buffer DE-B, mix by inverting, cool to room temperature, add to a centrifuge column and let stand for 1 minute. Centrifuge at 10,000 rpm for 1 minute and discard the eluent.

[0082] c. Add 500 μL of W1 solution, incubate at 12000 rpm for 1 min, then discard the effluent;

[0083] d. Add 700 μL of W2 solution, incubate at 12000 rpm for 1 min, discard the eluent, and repeat this step once;

[0084] e. Centrifuge at 10000 rpm for 2 min, transfer to a new centrifuge tube, let stand for 1 min, add 30 μL of 55℃ deionized water, and let stand for 1 min;

[0085] f. Centrifuge at 10000g for 1 min to elute DNA. After determining the DNA concentration, store at -20℃.

[0086] 4. Connect the T-carrier

[0087] Prepare the connection system according to Table 1.4, mix thoroughly by suction and beat, and react at room temperature for 10 minutes to achieve conversion.

[0088] Table 1.4 Connection System

[0089]

[0090] 5. Transformed competent cells

[0091] a. After the ligation reaction was completed, the ligation product was added to 50 μL of competent colon cells (TransGold (Beijing)) and incubated on ice for 30 min; then heat-shocked in a water bath at 42℃ for 45 s, placed on ice for 2 min, and 500 μL of antibiotic-free LB was added. The cells were then incubated at 37℃ for 45 min at 200 rpm.

[0092] b. Centrifuge at 3500 rpm for 2 min, discard 500 μL of supernatant culture medium, mix the remaining sample by pipetting, spread on kanamycin-resistant LB plates (Kanamycin, Kana, 50 mg / mL), and incubate overnight;

[0093] c. The next day, select single clones from the plates and culture them in liquid Kana (50 mg / mL) resistant LB medium at 200 rpm and 37°C for 4 h.

[0094] d. Use M13-F (Table 1.5) and SmERF105-R (Table 1.1) as a primer pair for bacterial detection. The system is shown in Table 1.6 and the procedure is shown in Table 1.7.

[0095] e. Based on the electrophoresis results, select PCR-positive clones for sequencing;

[0096] f. Sequence alignment of sequencing results yields positive clones.

[0097] Table 1.5 Primer Information

[0098]

[0099] Table 1.6 PCR system for bacterial detection

[0100]

[0101] Table 1.7 PCR Procedure for Bacterial Detection

[0102]

[0103] 6. Plasmid extraction

[0104] a. Take 10 μL of positive bacterial culture into 5 mL of Kana (50 mg / mL) resistant LB medium and incubate overnight; centrifuge at 10000 rpm for 1 min and discard the supernatant;

[0105] b. Use a plasmid extraction kit (EM101-02) to extract plasmids, add 250 μL of RB solution, and vortex until the solution is homogeneous;

[0106] c. Add 250 μL LB, gently invert 5-6 times, and let stand until a clear blue solution is formed;

[0107] d. Add 350 μL of NB, mix gently 5-6 times, let stand at room temperature for 2 minutes to form a yellow precipitate;

[0108] e. Centrifuge at 12000g for 5 min, transfer the supernatant to a centrifuge column, centrifuge at 10000g for 1 min, and discard the eluent;

[0109] f. Add 650 μL of WB, centrifuge at 12000 g for 1 min to elute. Repeat this step once;

[0110] Centrifuge at 12000g for 2 minutes to remove residue;

[0111] h. Place the centrifuge column in a clean EP tube, let it stand for 1 min, add 30 μL of 55℃ deionized water, and let it stand for 1 min;

[0112] Centrifuge at 12000g for 1 min, determine the concentration, and then freeze for storage.

[0113] 7. Experimental Results

[0114] Based on the genomic sequence information of *Salvia miltiorrhiza*, the SmERF105 gene sequence, 891 bp, was cloned. The sequence information is as follows:

[0115] >SmERF105

[0116] ATGATTAGCCATGCGTTCCTTCCTTCTCCTCCCATGAACCCGCCGCGAAGC

[0117] CGCCCCTTCAACCCCTTATATAAACATTTCTCACTCCATATTTTCCACTC

[0118] ACAACAAAAATTCAAATTCAAACAACAAATTCCAATATGTCTAATACACTTA

[0119] TCATGGCTTCTCCCGATGAAACCTCAGCTCTTGATCTCATACGCCAACACCT

[0120] CCTTGATGATTTTGCTTTCGCAGAAACTTACTGCTCATCTCAATCCCAAATC

[0121] TCTAGAACCTCCAGCTCAACCAGCTCCAATCTCTCCGATCTCACAACCGGC

[0122] GACTGTTTCGAATTCGAGACCAAACCGCACATTGCGATGAGAGAGAAGGC

[0123] GAAGCCGGCGCTCAACATCGCCATTCCGAAAGTGACCAACAAGGCTGCTC

[0124] TAATCCACCTCGCCGGCGCCGCTGTAGAGGATTCCGGCGACCGGAGACACT

[0125] TCAGAGGCGTGCGGCAGCGGCCGTGGGGGAAGTTCGCGGCGGAGATACGC

[0126] GACCCCAACCGGAAGGGGACTAGGGTTTGGCTGGGGACGTTCGACACCGC

[0127] GATGGAGGCCGCCAAGGCCTACGATAGGGCGGCGTTCCAGCTCAGAGGGA

[0128] GCAAGGCGATACTCAATTTCCCGCTCGAGATCGGCAGTATGGACCAATCTG

[0129] CGGTGCCGCAGATTGAGGCGGTGGTGTGCCGGAAGAGAAGGAGGGACGG

[0130] GGAGGGCGAGGAGAGAGAGAGGAAAGAGGTGAAAACGGAGAGTAGTGA

[0131] GTTGACGGCGGCGGTGCCGCTGACGCCGTCAAGTTGGACGGCCGTTTGGG

[0132] ATGGAGGGGAAGGGAAAGGGATATTTGAGGTCCCGCCGTTGTCGCCTTATCCACAAATGTCGTCGGTTATTCGTGTTTGA(SEQ ID NO.1)

[0133] Amino acid sequence

[0134] >SmERF105

[0135] MISHAFLPLSSHEPAAKPPPSTPYINTFLTPYFPLTTKIQIQTTNSNMSNTLIMAS

[0136] PDETSALDLIRQHLLDDFAFAETYCSSQSQISRTSSSTSSNLSDLTTGDCFEFETK

[0137] PHIAMREKAKPALNIAIPKVTNKAALIHLAGAAVEDSGDRRHFRGVRQRPWG

[0138] KFAAEIRDPNRKGTRVWLGTFDTAMEAAKAYDRAAFQLRGSKAILNFPLEIGS

[0139] MDQSAVPQIEAVVCRKRRRDGEGEERERKEVKTESSELTAAVPLTPSSWTAVWDGGEGKGIFEVPPLSPYPQMSSVIRV(SEQ ID NO.2)

[0140] II. Study on the regulatory effects of SmERF105 on tanshinone pathway genes and transport genes

[0141] (I) Yeast One-Hybrid Experiment

[0142] 1. Obtaining the starter sequence

[0143] a. Using tanshinone cDNA as a template, PCR amplification was performed using paired primers pCYP76AH3-F and pCYP76AH3-R, pKSL1-F and pKSL1-R, and pABCG1-F and pABCG1-R (Table 2.1) in a KOD-FX enzyme reaction system.

[0144] b. The PCR product was gel-recovered, ligated into Bluntzero, transformed into competent E. coli cells, and 500 μL of antibiotic-free LB liquid medium was added. The cells were cultured on a shaker at 220 rpm for 1 h and then plated on kanamycin (Kana 50 mg / mL) resistant plates.

[0145] c. The next day, single clones were picked, 500 μL of resistant LB liquid medium was added, and the culture was carried out in a shaker at 220 rpm for 4 h. The bacteria were tested using the rTaq system, and positive clones were sent for testing.

[0146] d. Sequence alignment of sequencing results yielded the promoter sequences of pABCG1, pCYP76AH3, and pKSL1.

[0147] Table 2.1 Primer Information

[0148]

[0149]

[0150] 2. Construction of Pb42ad vector

[0151] a. Using Pb42ad-SmERF105-F and Pb42ad-SmERF105-R as a pair of primers (Table 2.1), and with the cloned SmERF105 as a template, homologous arms were ligated using the KOD-FX enzyme reaction system.

[0152] b. The Pb42ad empty vector strain was cultured overnight, and the plasmid was extracted. It was then digested with EcoRI-HF and XhoI double enzymes. The system is shown in Table 2.2. The reaction was carried out at 37℃ for 2 hours.

[0153] Table 2.2 Pb42ad vector enzyme digestion system

[0154]

[0155] c. Following the instructions of the gel extraction kit, the PCR products and enzyme digestion products were gel extracted together, homologous recombination was ligated, and the mixture was transformed into Trans1T-1. The mixture was then plated on LB ampicillin-resistant plates (Ampicillin, Amp, 50 mg / L) and incubated in the dark at 37°C for 16 h.

[0156] d. Pick a single colony, add 500 μL LB (Amp, 50 mg / L), incubate at 37℃ and 220 rpm for 4 h, use SmERF105-F and SmERF105-R (Table 1.1) as forward and reverse primers, and use rTaq enzyme for bacterial detection. Send positive clones for testing.

[0157] e. Obtain positive clones, extract plasmids, and store at -20℃.

[0158] 3. Construction of LacZ vector

[0159] a. Using LacZ-pKSL1-F and LacZ-pKSL1-R, LacZ-pABCG1-F and LacZ-pABCG1-R, and LacZ-pCYP76AH3-F and LacZ-pCYP76AH3-R as primer pairs, LacZ-pKSL1, LacZ-pABCG1-F and LacZ-pABCG1-R, and LacZ-pCYP76AH3-F and LacZ-pCYP76AH3-R, respectively, double strands were synthesized by annealing. The sequences are shown in Table 2.1.

[0160] b. Extract the empty LacZ vector plasmid, perform double digestion using the same restriction endonuclease as Pb42ad, and recover the linearized plasmid using a gel.

[0161] c. Use the T4 ligase ligation system and ligate overnight at 16°C;

[0162] d. The next day, the ligation product was transformed into Trans1T-1, plated on LB resistant plates (Amp 50mg / L), and incubated in the dark at 37℃ for 16h;

[0163] e. Pick a single colony, add 500 μL LLB (Amp 50 mg / L), incubate at 37℃ and 220 rpm for 4 h, and send positive clones for testing after bacterial examination;

[0164] f. Obtain positive clones, extract plasmids, and store at -20℃.

[0165] 4. Preparation of EGY48 yeast competent cells

[0166] a. Take out the EGY48 yeast strain, streak it on YPDA medium, and incubate it in the dark at 28°C for 2-3 days;

[0167] b. Pick a single colony of EGY48 yeast, add 500 μL of liquid YPDA medium, and activate overnight at 28°C and 200 rpm. Then, take 500 μL of the activated bacterial solution and add 5 mL of liquid YPDA medium to continue activation until OD200. 600 The OD600 was 0.6; 1 mL of bacterial culture was taken out and 20 mL of liquid YPDA was added to continue activation until the OD600 was 0.6;

[0168] c. Collect bacterial cells by centrifugation at 2000g at 4℃ for 5 min, resuspend the bacterial cells in 1.5 mL of 0.1M lithium acetate, transfer to a 2 mL centrifuge tube, centrifuge at 2000g at 4℃ for 2 min, discard the supernatant, repeat twice, and operate on ice.

[0169] d. Add 200 μL of 0.1 M lithium acetate to resuspend the bacterial cells to obtain competent yeast cells, and keep on ice until needed.

[0170] 5. Transformation of yeast competent cells using the target vector

[0171] a. Prepare the yeast reaction system according to Table 2.3. First, premix and dispense PEG3500, 1.0M LiAC and ssDNA, then add plasmid and water, and finally add 25μL of competent cells and mix well by pipetting.

[0172] b. Incubate at 30℃ for 30 min, heat shock at 42℃ for 15 min, and cool on ice for 2 min;

[0173] c. Centrifuge at 2000g at 4℃ for 5 min, discard the supernatant, wash twice with sterile water, resuspend in 200μL of sterile water, and then take 50μL to spread on SD-TU plates.

[0174] d. Incubate at 28℃ for 3 days, and a single colony will grow.

[0175] Table 2.3 Yeast competent cell transformation system

[0176]

[0177] 6. Colorimetric observation

[0178] a. Configure a qualitative flat panel and use it immediately upon preparation;

[0179] b. Pick a single yeast colony and dissolve it in 50 μL of sterile water. Take 4 μL and spot it onto a prepared qualitative plate. Incubate in the dark at 28°C for 2–3 days and observe the color development.

[0180] 7. Experimental Results

[0181] 7.1 Pathway Gene Promoter Analysis

[0182] Promoters for the pABCG1, pCYP76AH3, and pKSL1 genes were obtained from *Salvia miltiorrhiza* DNA, with lengths of 1500 bp, 1283 bp, and 1543 bp, respectively. All three promoter sequences contain a GCC-box that can be recognized and bound by AP2 / ERF family transcription factors. (See below) Figure 1 The presence of these GCC-boxes provides a possibility for the regulation of AP2 / ERF family transcription factors.

[0183] 7.2 Results of yeast one-hybrid experiment

[0184] Yeast one-hybrid assays demonstrated that SmERF105 can bind to the GCC-box sequence in the promoter sequences of ABCG1, KSL1, and CYP76AH3, thereby activating the expression of the lacz reporter gene, generating β-galactosidase, which cleaves X-gal into galactose and the dark blue substrate 5-bromo-4-chloroindigo. Figure 2 .

[0185] (II) Gel Retention Experiment

[0186] 1. Carrier Construction

[0187] a. Cloning of the target fragment: Using the correctly sequenced target gene as a template, homologous arms were ligated using pGEX-4T-1-SmERF105-F and pGEX-4T-1-SmERF105-R as upstream and downstream primers, respectively. The primer sequences are shown in Table 2.4.

[0188] Table 2.4 Primer sequence information

[0189]

[0190] b. Extract the pGEX-4T-1 vector plasmid, and double-digest the pGEX-4T-1 vector with BamHI-HF and NotI-HF. The digestion systems are shown in Table 2.5.

[0191] Table 2.5 Vector Enzyme Digestion System

[0192]

[0193] c. The PCR products and the linearized vector after enzyme digestion were subjected to agarose gel electrophoresis, and the gels were cut and recovered separately.

[0194] d. Homologous cloning: Calculate the amount of DNA required for the recombination reaction according to the formula, prepare the reaction system as shown in Table 2.6 on ice, add each component, mix well by pipetting, react in a water bath at 37°C for 30 min, and place on ice for 2 min;

[0195] Table 2.6 Homologous recombination reaction system

[0196]

[0197]

[0198] e. Transformation into competent cells: Add 10 μL of the ligation product to 50 μL of competent colon cells and incubate on ice for 30 min;

[0199] f. Heat shock in a 42℃ water bath for 45s, place on ice for 2min, add 700μL of blank LB medium in a clean bench, and incubate at 37℃ for 45min at 200rpm.

[0200] g. After the culture is completed, centrifuge the bacterial culture, discard 500 μL of supernatant culture medium, and then mix the remaining bacterial culture by aspiration and spread it on the resistance plate. The bacterial culture transformed by pGEX-4T-1 ligation product is spread on LB agar plates of ampicillin (Amp 50 mg / L) and cultured for 16 h.

[0201] h. After the culture is completed, select single clones from the plate and culture them in the corresponding resistant liquid medium at 220 rpm and 37°C for 4 hours before bacterial testing.

[0202] i. pGEX-4T-1-F and pGEX-4T-1-R were used for bacterial detection of the pGEX-4T-1 vector. The primer sequences are shown in Table 2.4, the PCR system is shown in Table 1.6, and the PCR program used is shown in Table 1.7.

[0203] j. Select positive clones for sequencing, use vector primer sequences for sequencing, and perform sequence alignment on the sequencing results to obtain positive clones with correct sequences;

[0204] k. Extract plasmids from positive clones, transform them into Transetta strains, and obtain positive expression strains.

[0205] 2. Protein induction and expression

[0206] a. Take 10 μL of the correctly sequenced bacterial culture, add 700 μL of LB resistant liquid medium (Amp resistant, 50 mg / L), and incubate overnight at 37°C at 220 rpm for activation;

[0207] b. Take 100 μL of activated bacterial culture, add 5 mL of LB liquid medium with the corresponding resistance, and incubate at 220 rpm and 37℃ for 4-6 h;

[0208] c. Take 1 mL of the bacterial culture from step b, add 1000 mL of LB liquid medium containing the corresponding antibiotic, and incubate at 220 rpm and 37°C for 4-6 hours until OD (digesterone) is reached. 600 The value is around 0.6; place it on ice to cool for 30 minutes.

[0209] d. Add 500 μL of 1 mol / L (1 M) IPTG stock solution to make the final IPTG concentration of the bacterial culture 0.5 mM, induce at 180 rpm and 16℃ for 14 h;

[0210] e. After induction, centrifuge at 5000g for 10 min at 4℃ to remove the supernatant, collect the induced bacterial cells, resuspend in 100mL of pH7.4 PBS, wash off the culture medium, centrifuge at 5000rpm for 10 min to remove the supernatant, and resuspend the bacterial cells in 100mL of PBS.

[0211] f. Use an ultra-high pressure cell disruptor to disrupt the cells. Before disruption, add an appropriate amount of PMSF, DNase and magnesium ions, and disrupt twice at 800 bar.

[0212] Centrifuge at 5000g for 15 minutes at 4℃, and collect the supernatant;

[0213] 3. Protein purification

[0214] a. Instrument preparation: Rinse the instrument tubing with the ultrafiltration aqueous solution, then rinse with buffer solution, connect the His-Tag column, equilibrate the column with 0.5 mL / min buffer solution, and prepare for sample injection after the baseline has stabilized;

[0215] b. Sample loading: Take the purified SmERF72 transcription factor protein supernatant, filter it through a 0.22 μm filter membrane, and load the sample at 0.5 mL / min;

[0216] c. Impurity removal: Elute with a buffer solution containing a low concentration of imidazole at a rate of 0.5 mL / min to remove impurities;

[0217] d. Elution: Elute the protein with a buffer solution containing a high concentration of imidazole at a rate of 0.5 mL / min, collecting 1.4 mL of eluent into a 1.5 mL EP tube; detect the peak value, and collect 1.4 mL of eluent before and after the peak and during the elution process.

[0218] e. SDS-PAGE electrophoresis: Take 20 μL of eluent from each tube, add 5 μL of protein loading buffer, mix well, heat in a metal bath at 95°C for 7 min, cool to room temperature, and then perform SDS-PAGE electrophoresis analysis. Electrophoresis program: 80V, approximately 30 min, until the marker bands are basically separated; adjust to 140V, approximately 60 min, until the band positions are appropriate.

[0219] f. Staining and destaining: After electrophoresis, remove the gel, cut off the stacking gel, transfer it to a culture dish, add 15 mL of Coomassie Brilliant Blue rapid staining solution, place it on a horizontal shaker at room temperature and shake at low speed for 30 min; after staining, recover the Coomassie Brilliant Blue rapid staining solution, add water to the culture dish to elute until the bands are clear, and identify the elution solution containing the target protein.

[0220] g. Concentration: Take a 10 kDa ultrafiltration centrifuge tube, add 10 mL of ultrapure water, and centrifuge at 4°C and 5000 g for 10 min. Discard the supernatant and the aqueous solution in the tube. Combine the elution buffer containing the target protein screened by SDS-PAGE electrophoresis, add it to the eluted ultrafiltration centrifuge tube, and centrifuge at 4°C and 5000 g for 30 min. Discard the eluent.

[0221] h. Washing: Add 15 mL of 1×PBS buffer (pH 7.4) to the ultrafiltration centrifuge tube, centrifuge at 4°C and 5000 g for 30 min, and collect the liquid in the upper column, which is the concentrated and desalted protein solution.

[0222] i. Using the same method, replace the GST-tag column to purify the SmERF105 transcription factor protein.

[0223] 4. Gel retardation experiment

[0224] a. Probe preparation: Take 4.5 μL F and 4.5 μL R, add 1 μL T4 buffer, anneal and connect at 95℃ for 15 min, and then dilute with sterile water to the appropriate concentration;

[0225] b. Preparation of EMSA gel: Add each component in sequence according to the system in Table 2.7 to prepare polyacrylamide gel. Before adding TEMED, mix the other components thoroughly. After adding TEMED and mixing, pour the gel immediately to avoid the generation of air bubbles.

[0226] Table 2.7 EMSA Electrophoresis Gel Formulation System

[0227]

[0228] c. Reaction system: There are six reaction systems: negative control reaction, sample reaction, cold probe competition reaction 1, cold probe competition reaction 2, cold probe competition reaction 3, and mutation probe reaction. Probe information is shown in Table 2.8. Mix well before adding the labeled probe, react at 25℃ for 10 min, then add the labeled probe and react at 25℃ for 20 min; the reaction system is shown in Tables 2.9 to 2.13.

[0229] d. Electrophoresis: Use 0.5×TBE as electrophoresis buffer, electrophoresis at 60V for 30 min, then electrophoresis at 90V for about 50 min, until the blue bromophenol blue dye in the EMSA / Gel-Shift loading buffer reaches 1 / 4 of the lower edge of the gel, then stop electrophoresis;

[0230] e. Transfer: Take out the gel and cut it to the appropriate size. Cut the corner mark on the nylon membrane and immerse it in 0.5×TBE. Perform wet transfer at 200mA for 45min. The transfer solution should be pre-cooled and the electrophoresis tank should be placed in an ice box to prevent heat generation during electrophoresis.

[0231] f. UV crosslinking: After the transfer is complete, remove the transfer clamp and gently take out the membrane. Place it face up in a square culture dish and crosslink it for 15 minutes at a distance of about 15 cm from the UV lamp.

[0232] g. Elution and equilibration: Melt the blocking solution and elution solution in a 45°C water bath beforehand. Add 15 mL of the blocking solution to a disposable culture dish and incubate on a horizontal shaker at room temperature for 15 min. Replace the blocking solution from the previous step with 15 mL of blocking solution containing streptavidin-HRP conjugate and incubate on a horizontal shaker at room temperature in the dark for 15 min. Elute three times with 15 mL of 1× washing solution on a shaker at room temperature in the dark, 5 min each time. Finally, incubate with equilibration solution under the same conditions for 5 min.

[0233] h. Detection: Mix 3 mL of ECL moon A and 3 mL of ECL moon B solution and use immediately. Take out the nylon membrane with tweezers, absorb the excess equilibration solution with filter paper, place it face up in the prepared ECL moon working solution, and let the working solution completely cover the nylon membrane. Let it stand at room temperature in the dark for 2 minutes, then take out the nylon membrane and observe it with a chemiluminescence imaging system.

[0234] Table 2.8 Probe Information Table

[0235]

[0236]

[0237] Table 2.9 Negative Control Reaction System

[0238]

[0239] Table 2.10 Sample Reaction System

[0240]

[0241] Table 2.11 Competitive Probe Reaction 1 System

[0242]

[0243]

[0244] Table 2.12 Competitive Probe Reaction 2 System

[0245]

[0246] Table 2.13 Competitive probe reaction system 3

[0247]

[0248] 5. Experimental Results

[0249] 5.1 Protein Expression Results

[0250] AKTA protein purification results showed that recombinant SmERF105 protein was obtained, such as... Figure 3 As shown.

[0251] 5.2 EMSA Results

[0252] The purified protein and corresponding probes were subjected to EMSA experiments. The results showed that SmERF105 could bind to probes Probe-KSL1, Probe-CYP76AH3, and Probe-ABCG1, respectively. Figure 4 Furthermore, as the concentration of the competing probe increases, the target protein band gradually fades, indicating that the binding of the labeled probe and the protein can be inhibited by the unlabeled competing probe. These results demonstrate that SmERF105 can bind to the promoter sequence of the target gene in vitro, further suggesting that it may have the same transcriptional regulatory role in Danshen (Salvia miltiorrhiza).

[0253] (III) Dual-luciferase assay

[0254] 1. Construction of the report carrier

[0255] a. Extract pGreenII 0800 and pGreenII 62-SK [1] The empty vector plasmid was double-digested with HindⅢ-HF (NEB (USA)) and BamHⅠ-HF (NEB (USA)) as restriction endonucleases and reacted at 37℃ for 2 h.

[0256] [1]Hellens,RP,Allan,AC,Friel,EN,Bolitho,K.,Grafton,K.,Templeton,MD,Karunairetnam,S.,Gleave,AP,&Laing,WA(2005).Transientexpression vectors for functional genomics,quantification of promoter activity and RNAsilencing in plants.Plant methods,1,13.https: / / doi.org / 10.1186 / 1746-4811-1-13

[0257] b. Using pGreenII 0800-ABCG1-F and pGreenII 0800-ABCG1-R, pGreenII 0800-CYP76AH3-F and pGreenII 0800-CYP76AH3-R, pGreenII 0800-KSL1-F and pGreenII 0800-KSL1 as primer pairs (primer information is shown in Table 2.14), homologous arm fragments were ligated using the cloned ABCG1, CYP76AH3, and KSL1 promoter sequences as templates; simultaneously, PCR products of pGreenII 62-SK-ERF105 ligated with homologous arms were obtained;

[0258] Table 2.14 Primer Information

[0259]

[0260]

[0261] c. Recover enzyme digestion products and PCR products from the gel. Homologous recombinations pGreenII 0800-ABCG1, pGreenII 0800-CYP76AH3, pGreenII 0800-KSL1, and pGreenII 62-SK-ERF105 were transformed into E. coli. The pGreenII 0800 vector was detected using pGreenII0800-F and pGreenII 0800-R as forward and reverse primers, and the pGreenII 62-SK vector was detected using pGreenII 62-SK-F and pGreenII 62-SK-R as forward and reverse primers. Positive clones were sent for testing.

[0262] d. Obtain positive clones of pGreenII 0800-ABCG1, pGreenII 0800-CYP76AH3, pGreenII 0800-KSL1 and pGreenII 62-SK-ERF105, culture them, extract plasmids, and store them at -20℃ for later use.

[0263] 2. Transformation of Agrobacterium

[0264] a. Positive clones of pGreenII 0800-ABCG1, pGreenII 0800-CYP76AH3, pGreenII 0800-KSL1, and pGreenII 62-SK-ERF105 were transformed into GV3101 strain containing the psoup plasmid, while empty vectors pGreenII 0800 and pGreenII 62-SK were transformed into Agrobacterium as negative controls;

[0265] b. Ice bath for 5 min, liquid nitrogen flash freezing for 5 min, heat shock at 37℃ for 5 min, ice bath for 5 min;

[0266] c. Add 500 μL of antibiotic-free YEB, incubate at 28℃ and 200 rpm for 3 h;

[0267] d. After the culture is completed, centrifuge at 4000 rpm for 2 min, discard 500 μL of supernatant YEB medium in a clean bench, mix the remaining sample by pipetting and spread it on resistant YEB medium (Rifmpicin, Rif, 40 mg / L, Kana 50 mg / L), and incubate at 28℃ for 2 days.

[0268] e. Select a single clone, mix it, and then test for bacteria to obtain a positive clone.

[0269] 3. Co-transfection of tobacco

[0270] a. According to Table 2.15, mix the bacterial suspensions of GV3101 (pGreenII 62-SK) and GV3101 (pGreenII 0800) at a 1:1 ratio according to different combinations, and inject the same amount of bacterial suspension into tobacco. The injection method is to inject the bacterial suspension from the back of the tobacco using a 10 mL syringe and incubate in the dark at room temperature for two days.

[0271] Table 2.15 shows the co-transfection combinations.

[0272]

[0273]

[0274] 4. Live imaging

[0275] Cut off tobacco leaves that have been transformed with Agrobacterium and cultured for 4-5 days, lay them flat on a culture dish with the back side facing up, and place them in the dark for 3 minutes. Spray the prepared 150 μg / mL Beetle Luciferin substrate evenly on the back of the tobacco leaves, place them in the dark for 7 minutes, and then place them in a live imaging system. Use a program to detect Luminescence fluorescence to detect and photograph the leaves, and analyze the results.

[0276] 5. Experimental Results

[0277] This section investigates the relationship between transcription factors and promoter sequences using a dual-luciferase system. Results show that SmERF105 can recognize and activate the promoter sequences of tanshinone pathway genes CYP76AH3, KSL1, and ABCG11 in tobacco. SmERF105 can also activate the transcription of ABCG1, CYP76AH3, and KSL1. (See below) Figure 5 .

[0278] (iv) In vivo functional studies of SmERF105

[0279] 1. Carrier Construction

[0280] a. Extract the empty CRISPR-CAS9 vector plasmid according to the plasmid extraction kit (Shandong Shunfeng Biotechnology Co., Ltd.), and perform single enzyme digestion on the extracted plasmid using BbsI-HF. The reaction system is shown in Table 2.16. The reaction was carried out at 37℃ for 2 hours.

[0281] Table 2.16 CRISPR-CAS9 enzyme digestion system

[0282]

[0283] Table 2.17 Primer Information

[0284]

[0285] b. Concatenate the gRNA1 and gRNA2 sequences into a linearized vector, such as... Figure 6 ;

[0286] c. The product was transformed into competent colon cells, plated on LB agar plates (50 mg / L Kana), and incubated for 16 h;

[0287] d. Pick single colonies, incubate them in liquid LB medium containing 50 mg / L Kana at 37°C and 220 rpm for 4 h, and perform bacterial detection using rTaq enzyme. Submit positive colonies for testing.

[0288] e. Obtain positive clones, extract plasmids and store them in a -20°C freezer.

[0289] 2. Plasmid transformation of Agrobacterium GV3101

[0290] See above.

[0291] 3. Leaf disc transformation

[0292] a. Take 50 μL of positive GV3101, add resistant YEB (Rif 40 mg / L, Kana 50 mg / L), and incubate overnight at 28℃ and 200 rpm;

[0293] b. Take 100 μL of the above bacterial culture, add 20 mL of resistant YEB (same as above), and incubate at 200 rpm until OD. 600 It is 0.6;

[0294] c. Centrifuge at 5000g for 6 min at low temperature, discard YEB, resuspend the bacterial cells in 10 mL MS liquid medium, add an appropriate amount of acetylsuccinone, and incubate at 28℃ and 100 rpm for 30 min.

[0295] d. Cut a 1cm piece 2 The leaves of the sterile Salvia miltiorrhiza seedlings on the left and right sides will be immersed in Agrobacterium tumefaciens solution at 28°C for 15 minutes.

[0296] e. After the inoculation is completed, use tweezers that have been burned and cooled to remove the leaf disc, place it on sterilized and dried filter paper with the reverse side facing up, absorb the excess bacterial solution on the leaf disc, and then place it on MS antibiotic-free plates with the front side facing up and co-incubate at 28°C for 2 days.

[0297] f. After co-culture, the leaf discs were transferred to cephalosporin and hygromycin MS resistant plates (Cefalothin, Cef 500 mg / L; Hygromycin B, Hyg 40 mg / L; N-Acetyl Aspartate, NAA 0.2 mg / L; N-(Phenylmethyl)-9H-purin-6-amine, 6BA 2 mg / L) and cultured in the dark at 28℃ for 5 days. Callus tissue grew at the wound edge, and the plates were then transferred to light for culture to induce shoot differentiation.

[0298] g. Change the culture medium every 14 days. After the bud clusters develop into seedlings, cut them off and transfer them to 1 / 2 MS medium to root.

[0299] 4. Extraction of DNA from transgenic plants

[0300] a. Take about 100 mg of genetically modified material, add it to a grinding bead, quick freeze it in liquid nitrogen, and grind it three times in a grinder at 55 Hz for 10 seconds;

[0301] b. Add 250 μL RB1 and 15 μL RNase A and mix thoroughly;

[0302] c. React at 55℃ for 15 minutes;

[0303] d. 11000g, centrifuge for 6 min, and transfer the supernatant to a new EP tube;

[0304] e. Add 100 μL PB1, mix well, incubate on ice for 5 min, and centrifuge at 12000g for 5 min;

[0305] f. Transfer the supernatant to a new EP tube, add 375 μL of BB1 and mix well;

[0306] g. Transfer to a centrifuge column and centrifuge at 12000g for 30s;

[0307] h. Add 500 μL CB1, centrifuge at 12000 rpm for 30 seconds;

[0308] i. Add 500 μL of WB1 and centrifuge at 12000 g for 30 seconds. Repeat the step once.

[0309] Centrifuge at 12000g for 2 minutes;

[0310] k. Place the centrifuge column in a new EP tube and let it stand for 2 minutes. Then add 50 μL of deionized water at 60°C and let it stand for 1 minute.

[0311] Centrifuge at 12000g for 1 min, determine DNA concentration, and freeze for storage.

[0312] 5. Identification and culture of transgenic plants

[0313] a. Perform PCR using Cas-F and Cas-R as forward and reverse primers respectively to verify whether GV3101 infection was successful;

[0314] b. Perform PCR using SmERF105-id-F and SmERF105-id-R (Table 2.17) as forward and reverse primers to verify whether the knockout was successful;

[0315] c. Positive seedlings are transferred to soil for cultivation, and samples are taken for testing after 45 days.

[0316] 6. Gene expression analysis

[0317] RNA was extracted from the samples according to the method described above and reverse transcribed into cDNA. The qPCR reaction system was prepared according to Table 2.17, and qPCR was performed using the three-step method. The reaction procedure is shown in Table 2.18. The relative expression levels of the genes were calculated using the Ct method.

[0318] Table 2.17 qPCR reaction system

[0319]

[0320] Table 2.18 qPCR Procedure

[0321]

[0322] 7. Metabolic analysis of tanshinone components in transgenic plants

[0323] a. Preparation of test sample: Take the root system of transgenic seedlings, dry it at low temperature in a freeze dryer, add grinding beads and grind it in a grinder, weigh 10mg of sample, add 1mL of 80% methanol for low temperature ultrasonic extraction for 60min, centrifuge at 13000g at 4℃ for 10min, and take 100μL of supernatant to obtain the sample.

[0324] b. Preparation of standard solutions: Weigh appropriate amounts of tanshinone IIA and cryptotanshinone reference standards, dissolve them in methanol and bring the volume to 2 mL, then dilute with methanol in a gradient to prepare standard solutions, and store them in the dark at low temperature.

[0325] c. Chromatographic conditions: The column was an Agilent ZORBAX SB-C18 (3.5 μm, 2.1 mm × 150 mm); the mobile phase was gradient elution, with acetonitrile as phase A and 0.1% formic acid aqueous solution as phase B, gradient elution: 0 min, 60% A, 5 min, 70% A; the flow rate was 0.3 mL / min; the column temperature was 40 °C; the injection volume was 1 μL.

[0326] d. Mass spectrometry conditions: Electrospray ionization (ESI) and multiple reaction monitoring (MRM) were used. Positive ion mode was employed; nitrogen was used as both the nebulizer and drying gas; high-purity nitrogen was used as the collision gas; capillary voltage was 4000 V; collision gas pressure was 40 psi; sheath flow temperature was 350 °C; drying temperature was 325 °C; and drying gas flow rate was 12 L / min. Standard solutions and internal standard solutions of certain concentrations were injected, and full scan analysis of product ions was performed under ESI ionization. MRM parameters are shown in Table 2.19.

[0327] e. Data processing: The content of tanshinone in the sample was calculated using the standard curve method.

[0328] Table 2.19 MRM parameters of tanshinone components

[0329]

[0330] 8. Data Processing Methods

[0331] Each sample group was tested with three biological replicates. The mean and standard deviation within each group were calculated. The data were then assessed to determine if they conformed to a normal distribution. If they did, a one-way ANOVA was performed to calculate the significance of differences between groups.

[0332] 9. Experimental Results

[0333] 9.1 Identification of transgenic Salvia miltiorrhiza plants

[0334] Three positive gene knockout plants were identified, namely 21, 41, and 68, see [link to relevant documentation]. Figure 7 .

[0335] 9.2 Gene Quantification and Tanshinone Content Determination Analysis

[0336] The expression levels of SmKSL1, SmABCG1, and SmCYP76AH3 in the SmERF105 gene knockout line were significantly lower than those in the empty vector line. Content assays showed that the contents of all four tanshinones were significantly reduced in the SmERF105 gene knockout Tanshinone line. Figures 8-9 In summary, this indicates that SmERF105 has a positive regulatory effect on tanshinone.

[0337] We discovered that SmERF105 can recognize the GCC-box in the promoter regions of pathway genes KSL1, CYP76AH3, and the transport gene ABCG1, and activate transcription. In vivo functional validation experiments showed that knocking out SmERF105 significantly reduced the content of tanshinone components, and significantly decreased the expression levels of KSL1, CYP76AH3, and the transport gene ABCG1. These results indicate that SmERF105 can regulate the transcription of pathway genes KSL1, CYP76AH3, and the transport gene ABCG1, thereby regulating the accumulation of tanshinone. It is the first regulatory factor discovered in *Salvia miltiorrhiza* to synergistically regulate tanshinone biosynthesis and transport, and can be used for quality control and molecular-assisted breeding of *Salvia miltiorrhiza*, providing insights for the regulation of active ingredients in other medicinal materials and contributing to the sustainable utilization of traditional Chinese medicine resources.

[0338] Note: The above examples are only used to illustrate the present invention and are not intended to limit the technical solutions described in the present invention; therefore, although the present invention has been described in detail with reference to the above embodiments, those skilled in the art should understand that modifications or equivalent substitutions can still be made to the present invention; and all technical solutions and improvements that do not depart from the spirit and scope of the present invention should be covered within the scope of the claims of the present invention.

Claims

1. A transcription factor SmERF105 that synergistically regulates the biosynthesis and transport of tanshinone, characterized in that, Its nucleotide sequence contains at least one of the following: a. The nucleotide sequence shown in SEQ ID NO.1; or b. A nucleotide sequence complementary to the nucleotide sequence shown in SEQ ID NO. 1; or c. A nucleotide sequence that overlaps with the nucleotide sequence shown in SEQ ID NO.1 and has the same coding function; or d. A nucleotide sequence that hybridizes to the nucleotide sequence shown in SEQ ID NO.1 and has the same coding function; or e. The nucleotide sequences amplified by at least one of the following primer pairs: 1) SEQ ID NO.3 and SEQ ID NO.4; 2) SEQ ID NO.6 and SEQ ID NO.7; 3) SEQ ID NO.20 and SEQ ID NO.21; 4) SEQ ID NO.39 and SEQ ID NO.40; 5) SEQ ID NO. 55 and SEQ ID NO. 56; or A gene mutation is performed on the nucleotide sequences of a, b, c, d, or e to obtain nucleotide sequences with the same coding function; or A nucleotide sequence that has at least 70% homology with and has the same coding function as the nucleotide sequences in a, b, c, d, or e.

2. The transcription factor SmERF105 of claim 1 is used to prepare products for cloning, replication and / or encoding expression of transcription factor SmERF105, or transcription factor SmERF105 polypeptides or proteins.

3. A nucleic acid construct, characterized in that, It contains the transcription factor SmERF105 and the regulatory sequence as described in claim 1.

4. A carrier, characterized in that, It contains the transcription factor SmERF105 as described in claim 1 and / or a nucleic acid construct as described in claim 3.

5. A cell, characterized in that, Contains the transcription factor SmERF105 as described in claim 1, and / or a nucleic acid construct as described in claim 3, and / or a vector as described in claim 4.

6. A transcription factor SmERF105 polypeptide or protein, characterized in that, Its amino acid sequence contains at least one of the following: a. The amino acid sequence shown in SEQ ID NO.2; or b. The amino acid sequence encoded by the transcription factor SmERF105, which co-regulates the biosynthesis and transport of tanshinone, as described in claim 1; or c. The amino acid sequence encoded by the nucleic acid construct according to claim 3; or d. The amino acid sequence encoded by the vector according to claim 4; or e. The cell-encoded amino acid sequence as described in claim 5; or f. A sequence that has at least 70% homology with the amino acid sequence of a, or b, or c, or d, or e.

7. A plant, plant tissue, or plant organ, characterized in that, Contains the transcription factor SmERF105 as described in claim 1, and / or a nucleic acid construct as described in claim 3, and / or a vector as described in claim 4, and / or a cell as described in claim 5, and / or a polypeptide or protein of the transcription factor SmERF105 as described in claim 6.

8. The transcription factor SmERF105 of claim 1, and / or a nucleic acid construct of claim 3, and / or a vector of claim 4, and / or a cell of claim 5, and / or a transcription factor SmERF105 polypeptide or protein of claim 6, and / or a plant or plant tissue or plant organ of claim 7, for the purpose of synergistically regulating the biosynthesis and transport of tanshinone or preparing products that synergistically regulate the biosynthesis and transport of tanshinone.

9. A product characterized in that, Contains the transcription factor SmERF105 of claim 1, and / or a nucleic acid construct of claim 3, and / or a vector of claim 4, and / or a cell of claim 5, and / or a transcription factor SmERF105 polypeptide or protein of claim 6, and / or a plant or plant tissue or plant organ of claim 7.

10. A method for regulating the biosynthesis and transport of tanshinone, characterized in that the steps include... include: The transcription factor SmERF105 of claim 1, and / or a nucleic acid construct of claim 3, and / or a vector of claim 4, and / or a cell of claim 5, and / or a transcription factor SmERF105 polypeptide or protein of claim 6, and / or a plant or plant tissue or plant organ of claim 7 are used for culturing.

11. A primer pair for amplification or detection of SmERF105, a transcription factor regulating tanshinone biosynthesis and transport, characterized in that, It contains at least one of the following: 1) SEQ ID NO.3 and SEQ ID NO.4; 2) SEQ ID NO.6 and SEQ ID NO.7; 3) SEQ ID NO.20 and SEQ ID NO.21; 4) SEQ ID NO.39 and SEQ ID NO.40; 5) SEQ ID NO.55 and SEQ ID NO.

56.

12. The primer pair for amplification or detection of transcription factor SmERF105, which regulates the biosynthesis and transport of tanshinone, as described in claim 11, is used for the amplification or detection of transcription factor SmERF105 and / or for the preparation of products for the amplification or detection of transcription factor SmERF105.

13. A product for amplifying or detecting transcription factor SmERF105, characterized in that, The primer pair containing the SmERF105 transcription factor that regulates the biosynthesis and transport of tanshinone as described in claim 11 is used for amplification or detection.